Literature DB >> 10949778

The importance of quality-of-life endpoints in clinical trials to the practicing oncologist.

S D Passik1, K L Kirsh.   

Abstract

Quality-of-life research has helped describe and draw attention to the human side of cancer treatment. The field has made tremendous advances and has influenced the treatment of cancer. The practicing oncologist can benefit greatly by keeping abreast of developments in this field and applying them to the selection of treatment modalities based on both treatment efficacy and the patient's wishes. In the future, quality-of-life research will probably continue to be integrated into the practice of oncology.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10949778     DOI： 10.1016/s0889-8588(05)70316-6

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  6 in total

1.  Quality of Life and Value Assessment in Health Care.

Authors:  Alicia Hall
Journal:  Health Care Anal       Date:  2020-03

2.  Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL).

Authors:  Patricia J Hollen; Richard J Gralla; John A Stewart; Jacinta M Meharchand; Rafal Wierzbicki; Natasha Leighl
Journal:  Support Care Cancer       Date:  2012-06-10       Impact factor: 3.603

3.  Measuring symptoms as a critical component of drug development and evaluation in hematological diseases.

Authors:  Loretta A Williams; Emre Yucel; Jorge E Cortes; Charles S Cleeland
Journal:  Clin Investig (Lond)       Date:  2013-12-01

4.  Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice.

Authors:  D Blum; D Koeberle; A Omlin; J Walker; R Von Moos; W Mingrone; S deWolf-Linder; S Hayoz; S Kaasa; F Strasser; K Ribi
Journal:  Support Care Cancer       Date:  2014-04-05       Impact factor: 3.603

5.  Electronic monitoring of symptoms and syndromes associated with cancer: methods of a randomized controlled trial SAKK 95/06 E-MOSAIC.

Authors:  David Blum; Dieter Koeberle; Karin Ribi; Shu-Fang Hsu Schmitz; Urs Utiger; Dirk Klingbiel; Florian Strasser
Journal:  BMC Palliat Care       Date:  2012-09-24       Impact factor: 3.234

6.  Predictors of health-related quality of life in patients with colorectal cancer.

Authors:  Kathleen J Yost; Elizabeth A Hahn; Alan M Zaslavsky; John Z Ayanian; Dee W West
Journal:  Health Qual Life Outcomes       Date:  2008-08-25       Impact factor: 3.186
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.